Effect of Co-administration Lidocaine and Dexmedetomidine on Quality of Recovery

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

January 28, 2021

Primary Completion Date

June 25, 2021

Study Completion Date

June 25, 2021

Conditions
LidocaineDexmedetomidineQuality of Recovery(QoR-40), Preoperative and Postoperative
Interventions
DRUG

Co-administration Lidocaine and Dexmedetomidine

Patients received a bolus infusion of lidocaine (2%; 1.5 mg/kg) and dexmedetomidine (0.5 µg/kg) over 10 min before the induction of anesthesia, and then lidocaine and dexmedetomidine were infused at a rate of 1.5 mg/kg/h and 0.4 µg/kg/h until close of the pneumoperitoneum, respectively.

DRUG

Dexmedetomidine infusion

Patients received a bolus infusion of dexmedetomidine (0.5 µg/kg over 10 min before the induction of anesthesia), and then dexmedetomidine was infused at a rate of 0.4 μg/kg/h until close of the pneumoperitoneum.

DRUG

Lidocaine infusion

Patients received a bolus infusion of lidocaine (2%; 1.5 mg/kg over 10 min before the induction of anesthesia), and then lidocaine was infused at a rate of 1.5 mg/kg/h until close of the pneumoperitoneum.

DRUG

Saline infusion

Patients received the same volume of normal saline 10 min before the induction of anesthesia, and then normal saline (0.9%) was continuously infused in an equal volume until close of the pneumoperitoneum.

Trial Locations (1)

246000

Department of Anqing Hospital Anesthesiology, Anqing

All Listed Sponsors
lead

Anqing Municipal Hospital

OTHER

NCT04706767 - Effect of Co-administration Lidocaine and Dexmedetomidine on Quality of Recovery | Biotech Hunter | Biotech Hunter